Abstract
Leishmaniasis is an uncommon infectious disease in the UK with a variety of clinical presentations. Physicians should remember to consider this diagnosis in patients with an appropriate travel history (including the Mediterranean basin) and seek help with diagnostics from a specialised parasitology laboratory. Treatment regimens may be unfamiliar to the general physician, and thus should also be discussed with an expert.
MeSH terms
-
Amphotericin B / therapeutic use
-
Antimony Sodium Gluconate / therapeutic use
-
Antiprotozoal Agents / therapeutic use
-
Humans
-
Immunocompromised Host
-
Leishmaniasis, Cutaneous / diagnosis*
-
Leishmaniasis, Cutaneous / drug therapy*
-
Leishmaniasis, Visceral / diagnosis*
-
Leishmaniasis, Visceral / drug therapy*
-
Leishmaniasis, Visceral / epidemiology
-
Male
-
Middle Aged
Substances
-
Antiprotozoal Agents
-
Amphotericin B
-
Antimony Sodium Gluconate